Elahere (AbbVie: mirvetuximab soravtansine-gynx) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 20...
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
alpha-targeted treatments, and regulatory approvals expansion. Strategic acquisitions enhance ADC capabilities, while localized manufacturing addresses tariff impacts to bolster market presence. Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Elahere Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The growth in the historic period of the Elahere market can be attributed to overcoming the constraints of traditional chemotherapy, addressing high relapse rates in ovarian cancer, and meeting unmet clinical needs in platinum-resistant cases. Developments in monoclonal antibody technology and early validation of fralpha as a therapeutic target also fueled growth. Looking ahead, the forecast period indicates further expansion driven by the increasing adoption of precision oncology, the growing use of biomarker testing, and an expanding ADC clinical pipeline. The supportive regulatory landscape for ta
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- AbbVie (ABBV) had its "buy" rating reaffirmed by Guggenheim.MarketBeat
- RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages [Yahoo! Finance]Yahoo! Finance
- Josh Brown: Biotech growth stocks immune to disruption risk [Yahoo! Finance]Yahoo! Finance
- Market Downturn: 2 Stocks to Buy and Hold Through Any Storm [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 3/11/26 - Form 4/A
- 3/9/26 - Form PRE
- 3/6/26 - Form 4
- ABBV's page on the SEC website